Heather Arranie 
Telehealth startup NeuroFlow announced on Tuesday, June 8th, 2021, that they have raised $20 million in a Series A funding round led by American Family Ventures. NeuroFlow provides digital mental health services that allow mental health professionals to monitor patient progress in real time. The new funds will accelerate the development of their digital platform, expand their suite of services, and grow its team.
Telehealth Startup NeuroFlow Raises $20 Million
NeuroFlow is a cloud-based digital health technology platform that uses evidence-based analytics to provide personalised mental health monitoring, assessment and treatment for individuals. The company provides a comprehensive suite of technologies and tools to enable Behavioral Health professionals to deliver real –time mental health insights and digital interventions. NeuroFlow utilises artificial intelligence (AI), machine learning (ML), and predictive analytics to help reduce the burden of complex behaviours on providers unable to accurately assess symptoms or track treatment outcomes.
NeuroFlow’s platform enables Behavioral Health professionals, including providers, psychologists, psychiatrists and other clinicians, to review patient progress, create personalised care plans, easily manage cases and track outcomes in real-time. The NeuroFlow services can generate actionable insights into patient behaviour in an efficient manner by combining all relevant patient data sources into one unified system that provides full visibility into treatment results. It also automatically generates daily assessments tailored to each patient’s needs with flexible delivery via secure messaging or phone call.
NeuroFlow recently raised $20 million in Series A funding from investors including venture capital arms of Kaiser Permanente Ventures and Philadelphia’s Independence Blue Cross–Highmark Blue Shield Company in its latest round of investments. These investments will leverage NeuroFlow’s ability to measure customer engagement levels on an ongoing basis and automate complex client care flows with prescriptive analytics capabilities for deeper insights at scale.
Funding Details
Telehealth startup NeuroFlow has recently announced that they have raised $20 million in funding from investors. This capital injection will help the company expand their current offerings and accelerate their roadmap for making mental health care more accessible and affordable. In addition, the startup will use the new funding to develop new products and services, expand their sales and marketing efforts, grow their development teams and extend into new markets. But, first, let’s take a closer look at the funding particulars.
Investors Involved
NeuroFlow, a Philadelphia-based company specialising in mental health technology, recently announced that it has raised $20 million in capital from investors. The funding was spearheaded by Rethink Impact, with participation from Greycroft partners and Revolution’s Rise of Rest seed fund.
Rethink Impact is a venture capital firm focused exclusively on investing in impact-driven entrepreneur teams tackling the world’s biggest problems—from education to healthcare to sustainability. They have largely invested in early-stage startups across the globe, but recent investments include healthcare and privacy ventures.
Greycroft partners is a venture capital firm focused on backing early stage digital media, Internet and mobile companies. They have invested in over 200 digital media companies, such as Huffington Post and Bandsintown (sold to LiveNation). Greycroft also invests in mental health ventures over the B2B and B2C spectrum.
Additional investors for NeuroFlow’s $20 million raise included Revolution’s Rise of Rest seed fund. Established by Steve Case—a pioneer of the Internet—Revolution’s mission is to invest in entrepreneurs outside Silicon Valley through its Rise of Rest Seed Fund. Through this fund they have sought out promising technologies tackling some of the world’s most urgent challenges, such as NeuroFlow’s innovative approach to mental healthcare technology.
These investors were instrumental in helping NeuroFlow reach its goal of raising $20 million worth of capital for their mental health technology platform.
How the Funds Will Be Used
NeuroFlow, a digital health company leveraging the power of AI, ML and behavioural science for mental health and emotional well-being, recently announced it has raised $20 million in a round of funding. NewView Capital led this round with participation from existing investors such as Pillar VC, Comcast Ventures and Real Ventures.
This new capital will allow NeuroFlow to continue developing its proprietary AI-powered platform that works with insurance providers, organisations, employers and individuals. Furthermore, it will further finance the company’s research into new capabilities such as automated emotion recognition and natural language processing. It will also empower NeuroFlow’s mission to drive commerce throughout its network of stakeholders to create accessible care for everyone.
This new funding round allows NeuroFlow to further solidify their position as the leader in AI-driven digital mental health technology. Medical professionals are now using their platform for remote monitoring, communication tools and risk assessments due to its easy implementation at both enterprise and consumer levels. Plus, NeuroFlow has successfully provided self-service features that allow users from all walks of life access to customizable care pathways while providing administrators with enhanced data collection and analytics capabilities.
NeuroFlow’s new funds will facilitate further research into how AI can improve patient outcomes while reducing costs overall in the healthcare sector. They plan on continuing down this path into an exciting next stage of personalised care models powered by real-time insights achieved through cloud computing technologies like AWS or Azure and best practices developed through proactive research projects already in the works at top universities such as Harvard Medical School and MIT.
Impact of Investment
Telehealth startup NeuroFlow has recently announced that it has raised $20 million in a combination of venture capital and debt financing. This funding boost will be used to develop new telehealth technologies, strengthen the company’s position in the market and accelerate its growth. This new influx of capital will have a major impact on the telehealth industry, and it will be interesting to see how the sector’s landscape changes due to this investment.
Growth of Telehealth Industry
The recent $20 million Series B raise by NeuroFlow, a telehealth and analytics platform, signals the ongoing growth of the telehealth industry. The round was led by Evolution Equity Partners, with participation from existing investors including CLAL, PCM Venture Capital, MissionOG, and Elevate Ventures.
The massive amount of funding reinforces telehealth’s status as one of the most booming industries in healthcare. According to a 2020 McKinsey report, telemedicine adoption will likely become the “new normal” for primary care with annual digital healthcare visits possibly reaching 1 billion by 2025 – up from less than 500 million in 2019.
The growth is being driven by not only technological advances but also structural changes across the healthcare system. For example, increasing provider acceptance of virtual solutions and rapid use of mobile health applications to address quality gaps and cost volatility has set off a wave of investment into remote clinical care solutions such as NeuroFlow’s platform.
The company intends to use the new resources to rapidly expand its nationwide customer base and further improve core product capabilities needed for commercial and clinical success.
Expansion of NeuroFlow’s Reach
NeuroFlow, a digital health platform that enables its customers to measure and improve mental well-being, has closed a $20 million financing round from investors. This capital injection will allow NeuroFlow to expand its reach by expanding its clinical capabilities, building out its enterprise collaborations, and supporting additional product feature growth for its mission to support care for the whole person.
The new funding will advance NeuroFlow’s ability to deliver end-to-end solutions for mental health assessment, coaching and care delivery to employers. As part of this effort, NeuroFlow plans on integrating additional data points into their existing platform of dynamic assessments, including biometrics from wearable devices such as FitBit or Oura Ring and self-reported metrics such as sleep or nutrition data which can contribute to overall wellness.
Furthermore, the investment will expand the product offering by rolling out performance management technology catering to top athletes and celebrities striving for peak brain performance through lifestyle optimization around mindful thinking and emotional intelligence. In addition, the NeuroFlow team plans on leveraging the funds to advance research initiatives around understanding stress levels and mood changes associated with work tasks and exploring new referral options with partners including telemedicine services.
The combination of increased funding and product offerings will help grow NeuroFlow’s presence domestically in the US market and open up global opportunities across Europe and Asia that would previously have been beyond their reach. In addition, the development of powerful tools for measuring mental health opens up a world of possibilities for those suffering from depression and anxiety who do not currently have adequate care due to numerous logistical challenges that accompany physical visits . As more people seek help through these digital channels, it should be no surprise that organisations like Neuroflow receive attention from investors aiming to capitalise on this market opportunity .
Conclusion
Telehealth startup NeuroFlow has raised $20 million in funding from venture capitalists, signalling strong support for their innovative technology and platform. This latest round of funding brings the total investment in the company to $32 million. It is further evidence of the growing trend of telehealth services and their impact on the healthcare industry. This article will review the implications of this funding round and conclude.
Summary of NeuroFlow’s Funding Round
NeuroFlow, a digital healthcare startup based in Philadelphia, has just raised a $20 million venture capital round from investors including Comcast Ventures and the Penn Medicine Innovation Fund. This round brings their total funding to date up to $22.6 million. This latest investment will expand NeuroFlow’s reach into mental health and wellness technology and support its mission to mainstream mental healthcare for all.
With this round of funding, NeuroFlow plans to integrate its popular mental wellbeing platform with several large partner health systems. By doing so, NeuroFlow will enable more accessible treatments for individuals suffering from mental disorders such as depression, anxiety, PTSD and substance abuse ailment. It also plans to invest further in developing its artificial intelligence capabilities by optimising the patient experience while enhancing clinical decision-making tools within its platform.
tags = telehealth startup neuroflow website, neuroflow app, network of care for providers, digital health company, patient engagement solutions and services, applied artificial intelligence, telehealth neuroflow ai series healthwiggersventurebeat, telehealth neuroflow ai healthwiggersventurebeat, telehealth neuroflow magellan healthwiggersventurebeat, telehealth neuroflow ai 20m healthwiggersventurebeat, telehealth neuroflow ai 20m series healthwiggersventurebeat, telehealth neuroflow ai series magellan healthwiggersventurebeat, telehealth neuroflow 20m series healthwiggersventurebeat, telehealth neuroflow 20m magellan healthwiggersventurebeat, telehealth neuroflow series healthwiggersventurebeat, telehealth neuroflow 20m healthwiggersventurebeat, direct health record integrations, telehealth adoption, digital mental health app
